Amphotericin B (AmB) is the drug of choice for the treatment of many fungal infections. Despite this, the drug can cause several serious side effects, one of which being nephrotoxicity (toxicity to the kidneys). Conventional AmB can be adapted into a lipid emulsion preparation, which can reduce the risk of nephrotoxicity, while preserving its efficacy and remaining a lower cost option. Unfortunately this does not solve the problem, and nephrotoxicity remains an issue for many patients.
Vitamin D deficiency has been found to be a major problem worldwide, and can increase the risk of kidney-related disease, including drug-induced nephrotoxicity. A recent study by Daniela Ferreira and colleagues at the University of Sao Paulo looked at standard and vitamin D-deficient rats and found that the deficient rats treated with AmB presented with impaired renal function. This suggests that vitamin D deficiency may play a key role in the development of AmB-induced nephrotoxicity. Therefore, the authors state that it is essential to monitor levels of vitamin D in patients treated with both conventional and lipid formulations of AmB, in order to reduce the development of kidney disease.
Share this post
Latest News posts
ELF holds their first Breathe Clean Air patient conference
December 19, 2023
Thoughts on the Aspergillosis Journey Five Years On – November 2023
November 24, 2023
Do you have asthma and Allergic Bronchopulmonary Aspergillosis?
November 6, 2023
Chronic illness diagnosis and grief
April 11, 2024
ABPA guidelines update 2024
April 11, 2024
Salbutamol nebuliser solution shortage
March 25, 2024
ELF holds their first Breathe Clean Air patient conference
December 19, 2023
Thoughts on the Aspergillosis Journey Five Years On – November 2023
November 24, 2023
Do you have asthma and Allergic Bronchopulmonary Aspergillosis?
November 6, 2023
Chronic illness diagnosis and grief
April 11, 2024
ABPA guidelines update 2024
April 11, 2024
Salbutamol nebuliser solution shortage
March 25, 2024
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video